Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2009
10/15/2009US20090258906 Cxcr2 antagonists
10/15/2009US20090258895 Pharmaceutical formulation and process comprising a solid dispersion of macrolide (tacrolimus)
10/15/2009US20090258882 2,4-Substituted Quinazolines as Lipid Kinase Inhibitors
10/15/2009US20090258857 Chemical compounds
10/15/2009US20090258856 Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
10/15/2009US20090258837 Analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation
10/15/2009US20090258832 Cytokines and Cytokine Receptors With Reduced Immunocencity
10/15/2009US20090258421 Embryonic stem cells and neural progenitor cells derived therefrom
10/15/2009US20090258070 Topical LFA-1 antagonists for use in localized treatment of immune related disorders
10/15/2009US20090258050 Controlled Drug Delivery Using a Zein Layer Modified with Levulinic Acid
10/15/2009US20090258035 Avian virus vaccines and uses thereof
10/15/2009US20090258033 HCV E1E2 vaccine compositions
10/15/2009US20090258022 protein comprising signal transduction domain for use in treatment and prevention of nervous system disorders; immunizing a mammal with a protein comprising the sequence of SEQ ID NO:2
10/15/2009US20090257980 Anti-virus therapy for respiratory diseases
10/15/2009US20090257957 Aerosolized LFA-1 antagonists for use in localized treatment of immune related disorders
10/15/2009CA2721088A1 Methods and compositions for accelerating the generation of regulatory t cells ex vivo
10/15/2009CA2720946A1 Compounds and compositions as protein kinase inhibitors
10/15/2009CA2720771A1 Triterpene saponins, methods of synthesis, and uses thereof
10/15/2009CA2720617A1 Modified cpn10 and prr signalling
10/15/2009CA2720547A1 New combination for use in the treatment of inflammatory disorders
10/15/2009CA2719189A1 Novel compositions and methods for the treatment of immune related diseases
10/15/2009CA2718191A1 Agent for treating disease
10/14/2009EP2108660A1 Inhibition of IL-17 production
10/14/2009EP2108655A1 Immune-modulating peptide
10/14/2009EP2108642A1 Jak inhibitor
10/14/2009EP2108370A1 Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
10/14/2009EP2108369A1 Compounds for the treatment of immunosuppression in the skin caused by aggressive agents
10/14/2009EP2107907A1 New combination for use in the treatment of inflammatory disorders
10/14/2009EP1848446B1 Use of iron(iii) complex compounds
10/14/2009EP1755604B1 Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin
10/14/2009EP1636235B1 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors
10/14/2009EP1494661B1 Ptx3 gene expression suppressing method
10/14/2009EP1410795B1 Remedies for allergic eye diseases
10/14/2009EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/14/2009EP1356046B1 Cytokine receptor zcytor19
10/14/2009EP1337527B1 Indolylmaleimide derivatives as protein kinase c inhibitors
10/14/2009EP1303302B1 Use of strains of the parapox ovis virus against organ fibrosis
10/14/2009EP1227843B1 Method and system to remove cytokine inhibitor in patients
10/14/2009EP0734251B1 Method of transmitting a biologically active material to a cell
10/14/2009CN101558062A Indolylmaleimide derivatives as kinase inhibitors
10/14/2009CN101555486A Application of human transcription factor HMBOX1 gene
10/14/2009CN101555448A Tonic wine for strengthening yang and health care
10/14/2009CN101555291A Extraction and separation technology of ginseng polysaccharides
10/14/2009CN101555213A Preparation method of N-(phenelyl)-2-hydroxybenzamide
10/14/2009CN101554480A Improved DNA vaccines for production-type animals
10/14/2009CN101554442A Oral blood-clearing preparation
10/14/2009CN101554399A Psoralea corylifolial extract with immunologic enhancement and application thereof
10/14/2009CN101554206A Composite plant feed additive
10/14/2009CN101554203A Biological feed
10/14/2009CN101554197A Functional polysaccharide tea and preparation method thereof
10/14/2009CN100548996C 5-phenylthiazole derivatives and its use for preparing medicine
10/14/2009CN100548378C Method for preparing nanometer sized rapamycin/chitosan enveloped carrier
10/14/2009CN100548373C Vaccines
10/14/2009CN100548329C Drugs including immunopotentiators and health foods and drinks
10/14/2009CN100548321C Application of extractive of Abarema elliptica in use for preparing antiallergic medication, food and cosmetic
10/14/2009CN100548308C Medicinal composition for self-immune diseases and organ transplantation exclusion
10/14/2009CN100548303C Combination product comprising melagatran and dexamethasone
10/14/2009CN100548292C A micro-emulsion containing Vitamin C and Vitamin E
10/14/2009CN100548289C Anthranilic acid amides and the derivatives thereof as cosmetic and pharmaceutical agents
10/14/2009CA2629057A1 Control of diseases associated with decrease of t-regulatory cells with a preparation of extended freeze-dried killed bacteria
10/13/2009US7601836 Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7
10/13/2009US7601817 For treating a disease medicated by TNF alpha including acute and chronic immune and immunoregulatory disorders and rheumatoid or osteo-arthritis
10/13/2009US7601816 Transcripts harboring inton 1, or fragment thereof; preventing or treating Alzheimer's Disease; ameliorating a neurodegenerative condition; modulating amyloid precursor protein; selectively inhibiting COX-3 or PCOX-1a activity
10/13/2009US7601813 Anti-GL50 antibodies
10/13/2009US7601812 Schistosoma protein for use in treatment of organ-specific autoimmune diseases
10/13/2009US7601809 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs
10/13/2009US7601727 Such as 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile; janus kinase 3 inhibitors; immunosuppressive agents; asthma
10/13/2009US7601712 Such as (1)-2-(4-chloro-3-((2-chloro-4-(((2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-ly)methoxy)benzoyl)amino)phenyl)-2-methylpropanoic acid; prostaglandin receptor agonists
10/13/2009US7601354 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
10/13/2009US7601349 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein
10/13/2009US7601337 Delivery of antipsychotics through an inhalation route
10/13/2009CA2455298C Condensed polycyclic compounds
10/13/2009CA2395866C Ophthalmic anti-allergy compositions suitable for use with contact lenses
10/13/2009CA2395438C Dry compositions containing hydrophobic amino acid
10/13/2009CA2322311C Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
10/13/2009CA2291218C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels
10/13/2009CA2236888C Medicament, in particular for modulation of the immune response in the control of viruses, tumors, bacteria and parasites
10/13/2009CA2222650C Tnf-.alpha. converting enzyme
10/13/2009CA2154488C Ganglioside-klh conjugate vaccines with qs-21
10/08/2009WO2009123316A1 Heterocyclic derivative and use thereof
10/08/2009WO2009123188A1 Partial peptide of survivin presented on mhc class ii molecule and use thereof
10/08/2009WO2009123119A1 Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same
10/08/2009WO2009122748A1 Therapeutic agent for respiratory diseases or allergic diseases
10/08/2009WO2009122719A1 Substance and composition both capable of imparting heat resistance
10/08/2009WO2009122707A1 1,3-dihydroisobenzofuran derivative
10/08/2009WO2009122337A1 Process for extracting active components from lippia polystachya and extract thus obtained
10/08/2009WO2009122183A1 New combination for use in the treatment of inflammatory disorders
10/08/2009WO2009122182A1 New combination for use in the treatment of inflammatory disorders
10/08/2009WO2009122181A1 New combination for use in the treatment of inflammatory disorders
10/08/2009WO2009122148A1 Fused thiophene and thiazole derivatives as pi3k kinase inhibitors
10/08/2009WO2009121690A1 Agent for treating disease
10/08/2009WO2009102893A3 Cyclic diaryl ether compounds as antagonists of prostaglandin d2 receptors
10/08/2009WO2009089399A3 Compositions comprising toll-like receptor or coreceptor antagonists and methods for ocular neuroprotection
10/08/2009WO2009087175A3 Allergy vaccine composition for mucosal administration
10/08/2009WO2009040045A3 Use of tyr-w-mif-1 and urocortin 2 as therapeutic agents
10/08/2009WO2009033758A3 Use of the peptide phpfhffvyk as therapeutic agent
10/08/2009US20090255004 G-Protein Coupled Receptor and Uses Therefor
10/08/2009US20090253897 Structural protein of adeno-associated virus with modified antigenicity, its production and its use
10/08/2009US20090253807 Aqueous suspension preparations
10/08/2009US20090253786 Synthesis, anti-allergic, anti-asthmatic and anti-inflammatory activities of CEE-1 and CEE-2
1 ... 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 ... 1172